GEODE CAPITAL MANAGEMENT, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 55 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$3,039,794
-7.0%
1,767,099
+5.4%
0.00%
Q2 2023$3,268,313
+57.9%
1,676,058
+125.1%
0.00%
Q1 2023$2,069,932
+84180.6%
744,580
+4.6%
0.00%
Q4 2022$2,456
-99.8%
711,968
+17.7%
0.00%
Q3 2022$1,554,000
+6.1%
604,850
-0.2%
0.00%
Q2 2022$1,465,000
-58.8%
605,765
-29.9%
0.00%
Q1 2022$3,557,000
-68.1%
863,550
-0.5%
0.00%
-100.0%
Q4 2021$11,158,000
+45.9%
867,728
+22.5%
0.00%0.0%
Q3 2021$7,647,000
+56.8%
708,068
+32.6%
0.00%0.0%
Q2 2021$4,876,000
+17.7%
534,096
+21.6%
0.00%0.0%
Q1 2021$4,141,000
+152.0%
439,232
+5.3%
0.00%
Q4 2020$1,643,000
+52.8%
417,013
+2.8%
0.00%
Q3 2020$1,075,000
-58.4%
405,722
+4.3%
0.00%
-100.0%
Q2 2020$2,582,000
+34.6%
388,932
+18.0%
0.00%
Q1 2020$1,918,000
-65.2%
329,576
-46.4%
0.00%
-100.0%
Q4 2019$5,516,000
+122.1%
615,084
+113.8%
0.00%0.0%
Q3 2019$2,484,000
-21.5%
287,669
+1.2%
0.00%0.0%
Q2 2019$3,165,000
+129.0%
284,135
+173.3%
0.00%
Q1 2019$1,382,000
-49.5%
103,946
-41.3%
0.00%
Q4 2018$2,736,000177,1560.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders